Crizotinib Inhibits Metabolic Inactivation of Gemcitabine in c-Met–driven Pancreatic Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Crizotinib Inhibits Metabolic Inactivation of Gemcitabine in c-Met–driven Pancreatic Carcinoma

Published:2013-10-01 Issue:22 Volume:73 Page:6745-6756
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Avan Amir,Caretti Viola,Funel Niccola,Galvani Elena,Maftouh Mina,Honeywell Richard J.,Lagerweij Tonny,Van Tellingen Olaf,Campani Daniela,Fuchs Dieter,Verheul Henk M.,Schuurhuis Gerrit-Jan,Boggi Ugo,Peters Godefridus J.,Würdinger Thomas,Giovannetti Elisa

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wortmannin Inhibits Cell Growth and Induces Apoptosis in Colorectal Cancer Cells by Suppressing the PI3K/AKT Pathway;Anti-Cancer Agents in Medicinal Chemistry;2024-07

2. Pharmacological mechanisms underlying the interaction of the nucleoside analogue gemcitabine with the c-MET inhibitor tivantinib in pancreatic cancer;Nucleosides, Nucleotides & Nucleic Acids;2024-02-29

3. Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic Target;International Journal of Biological Sciences;2024

4. Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy;Gut;2023-09-27

5. Savolitinib: A Promising Targeting Agent for Cancer;Cancers;2023-09-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP